89Zr-rituximab PET/CT to detect neurolymphomatosis
- 13 April 2016
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 91 (6) , 649-650
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antibody Positron Emission Tomography Imaging in Anticancer Drug DevelopmentJournal of Clinical Oncology, 2015
- Evaluation of 89Zr-rituximab Tracer by Cerenkov Luminescence Imaging and Correlation with PET in a Humanized Transgenic Mouse Model to Image NHLMolecular Imaging and Biology, 2013
- Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosisNuclear Medicine Communications, 2012
- Diagnosis and Management of NeurolymphomatosisThe Cancer Journal, 2012
- Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportBlood, 2010
- NeurolymphomatosisNeuro-Oncology, 2003